Systematic Review of Somatic Mutations in Splenic Marginal Zone Lymphoma.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
18 07 2019
18 07 2019
Historique:
received:
11
03
2019
accepted:
04
07
2019
entrez:
20
7
2019
pubmed:
20
7
2019
medline:
30
10
2020
Statut:
epublish
Résumé
The aims of this systematic review are to refine the catalogue of somatic variants in splenic marginal zone lymphoma (SMZL) and to provide a well-annotated, manually curated database of high-confidence somatic mutations to facilitate variant interpretation for further biological studies and future clinical implementation. Two independent reviewers systematically searched PubMed and Ovid in January 2019 and included studies that sequenced SMZL cases with confirmed diagnosis. The database included fourteen studies, comprising 2817 variants in over 1000 genes from 475 cases. We confirmed the high prevalence of NOTCH2, KLF2 and TP53 mutations and analysis of targeted genes further implicated TNFAIP3, KMT2D, and TRAF3 as recurrent targets of somatic mutation based on their high incidence across studies. The major limitations we encountered were the low number of patients with whole-genome, unbiased analysis and the relative sensitivities of differing sequencing approaches. Overall, we showed that there is little concordance between whole exome sequencing studies of SMZL. We strongly support the continuing unbiased analysis of the SMZL genome for mutations in all protein-coding genes and provide a valuable database resource to facilitate this endeavour that will ultimately improve our understanding of SMZL pathobiology.
Identifiants
pubmed: 31320741
doi: 10.1038/s41598-019-46906-1
pii: 10.1038/s41598-019-46906-1
pmc: PMC6639539
doi:
Types de publication
Journal Article
Meta-Analysis
Research Support, Non-U.S. Gov't
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
10444Subventions
Organisme : Cancer Research UK
Pays : United Kingdom
Références
Leukemia. 2014 Jun;28(6):1334-40
pubmed: 24296945
Clin Cancer Res. 2015 Mar 15;21(6):1487-96
pubmed: 25564152
BMC Cancer. 2015 Oct 24;15:773
pubmed: 26498442
Nucleic Acids Res. 2010 Sep;38(16):e164
pubmed: 20601685
Best Pract Res Clin Haematol. 2017 Mar - Jun;30(1-2):77-83
pubmed: 28288720
Syst Rev. 2015 Jan 01;4:1
pubmed: 25554246
Haematologica. 2017 Aug;102(8):e310-e312
pubmed: 28522570
J Exp Med. 2012 Aug 27;209(9):1553-65
pubmed: 22891276
Nat Med. 2015 Oct;21(10):1199-208
pubmed: 26366710
Nucleic Acids Res. 2018 Jan 4;46(D1):D1062-D1067
pubmed: 29165669
Blood. 2017 Feb 23;129(8):1042-1045
pubmed: 28069605
Blood. 2014 Mar 13;123(11):1637-46
pubmed: 24366360
Blood. 2014 Feb 20;123(8):1199-206
pubmed: 24300853
PLoS Med. 2009 Jul 21;6(7):e1000100
pubmed: 19621070
Genome Biol. 2016 Dec 16;17(1):261
pubmed: 27986087
Haematologica. 2012 Apr;97(4):595-8
pubmed: 22102703
Genome Biol. 2016 Jun 06;17(1):122
pubmed: 27268795
BMJ. 2015 Jan 02;350:g7647
pubmed: 25555855
Haematologica. 2017 Oct;102(10):1758-1766
pubmed: 28751561
PLoS One. 2013 Dec 13;8(12):e83244
pubmed: 24349473
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
Cell. 2008 Dec 12;135(6):1028-38
pubmed: 19070574
Leukemia. 2018 Nov;32(11):2412-2426
pubmed: 29556019
Leukemia. 2015 May;29(5):1177-85
pubmed: 25428260
Leukemia. 2015 Feb;29(2):503-7
pubmed: 25283840
Hum Mutat. 2016 Sep;37(9):865-76
pubmed: 27328919
Nucleic Acids Res. 2019 Jan 8;47(D1):D886-D894
pubmed: 30371827
J Exp Med. 2012 Aug 27;209(9):1537-51
pubmed: 22891273
Blood. 2016 Sep 8;128(10):1362-73
pubmed: 27335277
Nucleic Acids Res. 2017 Jan 4;45(D1):D777-D783
pubmed: 27899578
Nat Genet. 2014 Mar;46(3):310-5
pubmed: 24487276
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Clin Cancer Res. 2015 Sep 15;21(18):4174-4183
pubmed: 25779943
Blood. 2011 Nov 3;118(18):4930-4
pubmed: 21881048
Blood Adv. 2018 May 22;2(10):1116-1119
pubmed: 29773550
Nat Commun. 2015 Dec 07;6:8866
pubmed: 26638776